A preliminary indication that HLA-A*03:01 may be associated with visceral leishmaniasis development in people living with HIV in Ethiopia
PLOS Neglected Tropical Diseases · 2024
DOI: 10.1371/journal.pntd.0012000 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, 2024. Verfasst von Nicky de Vrij und 24 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Immunology Unit, Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium. Hauptthemen laut MEDLINE: Leishmaniasis, Visceral, HIV Infections, Coinfection. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Foundation Flanders (FWO), University of Antwerp Research Fund (BOF), Department of Economy, Science and Innovation of the Flemish Government.
Abstract (Originalsprache)
Human immunodeficiency virus (HIV) co-infection is a major challenge for visceral leishmaniasis (VL) control, particularly in Ethiopia where the incidence of both pathogens is high. VL-HIV often leads to high rates of antileishmanial treatment failure and recurrent VL disease relapses. Considering the high prevalence of HIV and Leishmania in the Ethiopian population, preventing the progression of asymptomatic Leishmania infection to disease would be a valuable asset to VL disease control and to the clinical management of people living with HIV (PLWH). However, such a strategy requires good understanding of risk factors for VL development. In immunocompetent individuals living in Brazil, India, or Iran, the Human Leukocyte Antigen (HLA) gene region has been associated with VL development. We used NanoTYPE, an Oxford Nanopore Technologies sequencing-based HLA genotyping method, to detect associations between HLA genotype and VL development by comparing 78 PLWH with VL history and 46 PLWH that controlled a Leishmania infection, all living in a VL endemic region of North-West Ethiopia. We identified an association between HLA-A*03:01 and increased risk of VL development (OR = 3.89). These data provide candidate HLA alleles that can be further explored for inclusion in a potential Leishmania screen-and-treat strategy in VL endemic regions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Clinical Immunology Unit, Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
- Adrem Data Lab, Department of Computer Science, University of Antwerp, Antwerp, Belgium.
- Clinical Reference Laboratory, Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
- Virus Ecology, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
- Leishmaniasis Research and Treatment Centre, University of Gondar, Gondar, Ethiopia.
- Médecins Sans Frontières, Abdurafi, Ethiopia.
ORCID-Profile: Nicky de Vrij, Wim Adriaensen
Förderung
- Research Foundation Flanders (FWO)
- University of Antwerp Research Fund (BOF)
- Department of Economy, Science and Innovation of the Flemish Government
- Fonds Wetenschappelijk Onderzoek
- Universiteit Antwerpen
- ITM-DGDC
- ITM-SOFI
Zitieren
APA
de Vrij, N., Vandoren, R., Ramadan, K., Van Hul, A., Ceulemans, A., Kassa, M., Melkamu, R., Yeshanew, A., Bogale, T., Beyene, H., Sisay, K., Kibret, A., Mersha, D., Cuypers, W. L., Vogt, F., van Henten, S., Ritmeijer, K., Pham, T. T., Meysman, P., …, & Adriaensen, W. (2024). A preliminary indication that HLA-A*03:01 may be associated with visceral leishmaniasis development in people living with HIV in Ethiopia. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0012000
Vancouver
de Vrij N, Vandoren R, Ramadan K, Van Hul A, Ceulemans A, Kassa M, et al. A preliminary indication that HLA-A*03:01 may be associated with visceral leishmaniasis development in people living with HIV in Ethiopia. PLOS Neglected Tropical Diseases. 2024. doi:10.1371/journal.pntd.0012000
BibTeX
@article{deVrij2024,
author = {de Vrij, Nicky and Vandoren, Romi and Ramadan, Kadrie and Van Hul, Anke and Ceulemans, Ann and Kassa, Mekibib and Melkamu, Roma and Yeshanew, Arega and Bogale, Tadfe and Beyene, Hailemariam and Sisay, Kasaye and Kibret, Aderajew and Mersha, Dagnew and Cuypers, Wim L and Vogt, Florian and van Henten, Saskia and Ritmeijer, Koert and Pham, Thao-Thy and Meysman, Pieter and Laukens, Kris and Cuypers, Bart and Diro, Ermias and Mohammed, Rezika and van Griensven, Johan and Adriaensen, Wim},
title = {A preliminary indication that HLA-A*03:01 may be associated with visceral leishmaniasis development in people living with HIV in Ethiopia},
journal = {PLOS Neglected Tropical Diseases},
year = {2024},
doi = {10.1371/journal.pntd.0012000}
}
EUVIMED